DLL3 RNAish: A Tissue-Based Biomarker for Targeted Therapy of Advanced Prostate Cancer

被引：0
|
作者：
Motanagh, Samaneh
Alnajar, Hussein [1 ]
Beltran, Himisha [2 ]
Vosoughi, Aram [3 ]
Sailer, Verena [4 ,5 ]
Elemento, Olivier
Sboner, Andrea [1 ]
Mosquera, Juan Miguel [1 ]
机构：
[1] Weill Cornell Med, New York, NY USA
[2] Harvard TH Chan Sch Publ Hlth, Dana Farber Canc Inst, Boston, MA USA
[3] Yale Univ, Sch Med, New Haven, CT USA
[4] Univ Med Ctr Schleswig Holstein, Campus Lubeck, Borstel, Germany
[5] Leibniz Lung Ctr, Res Ctr Borstel, Borstel, Germany
来源：
LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
978
引用
收藏
页码：941 / 942
页数：2
相关论文
共 50 条
  • [1] DLL3 RNAish: A Tissue-Based Biomarker for Targeted Therapy of Advanced Prostate Cancer
    Motanagh, Samaneh
    Alnajar, Hussein
    Beltran, Himisha
    Vosoughi, Aram
    Sailer, Verena
    Elemento, Olivier
    Sboner, Andrea
    Mosquera, Juan Miguel
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 941 - 942
  • [2] Validation of NEAT1 RNAish: A Tissue-Based Biomarker in Prostatic Cancer
    Alnajar, Hussein
    Sboner, Andrea
    Arora, Kshitij
    Park, Kyung
    Fontugne, Jacqueline
    Beltran, Himisha
    Rubin, Mark
    Mosquera, Juan Miguel
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 854 - 854
  • [3] Validation of NEAT1 RNAish: A Tissue-Based Biomarker in Prostatic Cancer
    Alnajar, Hussein
    Sboner, Andrea
    Arora, Kshitij
    Park, Kyung
    Fontugne, Jacqueline
    Beltran, Himisha
    Rubin, Mark
    Mosquera, Juan Miguel
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 854 - 854
  • [4] Targeting DLL3 in neuroendocrine prostate cancer
    Clemens Thoma
    Nature Reviews Urology, 2019, 16 : 330 - 330
  • [5] Targeting DLL3 in neuroendocrine prostate cancer
    Thoma, Clemens
    NATURE REVIEWS UROLOGY, 2019, 16 (06) : 330 - 330
  • [6] Targeted therapy in small cell lung cancer: can DLL3 notch up a victory?
    Lehman, Jonathan M.
    Horn, Leora
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S453 - S456
  • [7] Review of novel tissue-based biomarkers for prostate cancer: towards personalised and targeted medicine
    Osei, Ernest
    Swanson, Stephanie
    Sheraz, Lyba
    Ibrahim, Nada Khaled Fouad
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2022, 21 (04) : 566 - 575
  • [8] The prostate tissue-based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy
    Heaphy, Christopher M.
    Joshu, Corinne E.
    Barber, John R.
    Davis, Christine
    Lu, Jiayun
    Zarinshenas, Reza
    Giovannucci, Edward
    Mucci, Lorelei A.
    Stampfer, Meir J.
    Han, Misop
    De Marzo, Angelo M.
    Lotan, Tamara L.
    Platz, Elizabeth A.
    Meeker, Alan K.
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2022, 8 (05): : 481 - 491
  • [9] GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics
    G Kristiansen
    F R Fritzsche
    K Wassermann
    C Jäger
    A Tölle
    M Lein
    C Stephan
    K Jung
    C Pilarsky
    M Dietel
    H Moch
    British Journal of Cancer, 2008, 99 : 939 - 948
  • [10] GOLPH2 protein expression as a novel tissue biomarker for prostate cancer:: implications for tissue-based diagnostics
    Kristiansen, G.
    Fritzsche, F. R.
    Wassermann, K.
    Jaeger, C.
    Toelle, A.
    Lein, M.
    Stephan, C.
    Jung, K.
    Pilarsky, C.
    Dietel, M.
    Moch, H.
    BRITISH JOURNAL OF CANCER, 2008, 99 (06) : 939 - 948
12345